share_log

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

SEC announcement ·  Nov 9, 2023 08:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more